Richard A Miller Md bought $83k of CRVS
President and CEO at Corvus Pharmaceuticals, Inc.. 6,932 shares at an average of $12.04, traded May 18, 2026, filed May 20, 2026.
Score components
- +25RoleCEO
- +9Trade size$83k at market
- -5Relative to holdingsUnder 1% of holdings (0.6%)
- +8Price context52% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.3%, 3m +26.3%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000160, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 18, 2026 | POpen-market purchase Common Stockindirect: By Trust | +5,000 | $12.05 | $60k | 1,193,103 | May 20, 2026 |
| May 18, 2026 | POpen-market purchase Common Stockindirect: By Trust | +1,932 | $12.01 | $23k | 1,195,035 | May 20, 2026 |
Related signals
Other insiders at Corvus Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | CRVSbuy Corvus Pharmaceuticals, Inc. | David Scott Moore director | $250k 21,700 shares | - | |
| 53Moderate | Corvus Pharmaceuticals, Inc. | Peter A. Thompson director, owner | $4.9M 1,176,332 shares | -14% | |
| 53Moderate | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC director, owner | $4.9M 1,176,332 shares | -14% | |
| 74Notable | Corvus Pharmaceuticals, Inc. | Richard A Miller Md President and CEO | $1000k 577,634 shares | - | |
| 40Moderate | Corvus Pharmaceuticals, Inc. | William Benton Jones See Remarks | $35k 20,000 shares | +15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.